Sharma East India Hosp and Medical Research last traded at ₹80.40 (2026-10-13). Over the past month the stock moved -9.7%, three months the stock moved -14.9%, year the stock moved -46.5%. Its closing range over 52 weeks is ₹80.40 – ₹158.10, with the latest close 49.1% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1989, Sharma East India Hospital and Medical Research Ltd provides medical and healthcare services and real estate services[1]
Business Overview:[1] SEIHMR is provides medical & healthcare services. It runs a NABH accredited multi specialty hospital viz. Jaipur Hospital at Lal Kothi, Tonk Road, Jaipur.
In the latest quarter (Jun 2026), Sharma East India Hosp and Medical Research reported sales of ₹10.76 crore (+13.6%) and net profit of ₹0.26 crore (-18.8%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 10.76 | 0.86 | 7.99 | 0.26 | – |
| Mar 2026 | 7.47 | 1.01 | 13.52 | 0.43 | – |
| Dec 2025 | 9.61 | 0.76 | 7.91 | 0.18 | – |
| Sep 2025 | 9.38 | 0.94 | 10.02 | 0.32 | – |
| Jun 2025 | 9.47 | 0.92 | 9.71 | 0.32 | – |
| Mar 2025 | 5.98 | 0.81 | 13.55 | 0.37 | – |
| Dec 2024 | 8.15 | 0.86 | 10.55 | 0.29 | – |
| Sep 2024 | 9.02 | 1.11 | 12.31 | 0.34 | – |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +68.3% | +39.3% | +232.2% | +40.9% | +4.0% | +17.9% | +24.9% | +13.6% |
| Operating profit growth | +50.0% | -4.4% | – | +7.0% | -15.3% | -11.6% | +24.7% | -6.5% |
| Net profit growth | +17.2% | +26.1% | +825.0% | +28.0% | -5.9% | -37.9% | +16.2% | -18.8% |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | 12.3% | 10.6% | 13.6% | 9.7% | 10.0% | 7.9% | 13.5% | 8.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Sharma East India Hosp and Medical Research reported sales of ₹35.93 crore (+20.3%) and net profit of ₹1.24 crore (+0.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 35.93 | 3.63 | 10.10 | 1.24 | – |
| Mar 2025 | 29.87 | 3.66 | 12.25 | 1.24 | – |
| Mar 2024 | 18.52 | -1.88 | -10.15 | 0.66 | – |
| Mar 2023 | 20.73 | 3.30 | 15.92 | 0.83 | – |
| Mar 2022 | 17.04 | 2.25 | 13.20 | 0.68 | – |
| Mar 2021 | 8.13 | -0.66 | -8.12 | 0.64 | – |
| Mar 2020 | 16.17 | 1.93 | 11.94 | 0.31 | – |
| Mar 2019 | 14.73 | 0.64 | 4.34 | 0.27 | – |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -7.9% | +9.8% | -49.7% | +109.6% | +21.7% | -10.7% | +61.3% | +20.3% |
| Operating profit growth | -56.2% | +201.6% | -134.2% | – | +46.7% | -157.0% | – | -0.8% |
| Net profit growth | +107.7% | +14.8% | +106.5% | +6.3% | +22.1% | -20.5% | +87.9% | +0.0% |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | 4.3% | 11.9% | -8.1% | 13.2% | 15.9% | -10.2% | 12.3% | 10.1% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Sharma East India Hosp and Medical Research.
Get Free AI Stock Analysis FREE →No recent news available for Sharma East India Hosp and Medical Research.
Sharma East India Hosp and Medical Research shares were last quoted at ₹80.40 (-2.1% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Sharma East India Hosp and Medical Research has a price-to-earnings (P/E) ratio of 24.93 and a price-to-book (P/B) ratio of 2.26. The industry P/E is 102.95.
The 52-week high of Sharma East India Hosp and Medical Research is ₹173.05 and the 52-week low is ₹80.15.
The market capitalisation of Sharma East India Hosp and Medical Research is about ₹29.55 crore.
In the latest quarter (Jun 2026), Sharma East India Hosp and Medical Research reported sales of ₹10.76 crore (+13.6%) and net profit of ₹0.26 crore (-18.8%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Sharma East India Hosp and Medical Research has a 3-year ROE of -6.00%, 3-year profit growth of 14.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 53.63% of Sharma East India Hosp and Medical Research.
Sharma East India Hosp and Medical Research belongs to the Hospitals & Medical Services sector.